is farxiga a glp 1 GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Virtual Care Access: Compare Top

Consider Alternatives If Who Should Avoid Do not use if You have active cancer or a history of cancer (GH may promote tumor growth) You are pregnant or breastfeeding You have a pituitary tumor or untreated pituitary disorder You have had an allergic reaction to GHRH or its analogs You have uncontrolled diabetes or diabetic retinopathy You have active Cushing's disease or syndrome Use with caution if !You have diabetes (may affect blood sugar regulation) !You are taking insulin or diabetes medications !You have carpal tunnel syndrome (GH may worsen symptoms) !You have a history of joint pain or arthritis !You are over 65 years old (start with lower doses) !You have impaired kidney or liver function Administration How do I use it

Protecting your skin from the sun is a key part of that

It often resolves with slower dose escalation or small meal adjustments

Tumor Risk: The Dark Side of Growth Promoting Effects Cell proliferation and anti apoptotic effects IGF-1 LR3 activates the IGF-1R/PI3K/Akt pathway, inhibits the expression of key apoptotic proteins such as Caspase-3 and Bax, and promotes the synthesis of cell cycle proteins such as Cyclin D1, thereby accelerating cell proliferation